The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...
Sri Lanka’s attempt to emulate India’s pharmaceutical pricing system is a cautionary tale of misplaced ambition ...
MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...
Pharma major Venus Remedies on Tuesday said it has secured renewal of European Good Manufacturing Practices (EU-GMP) certification by Infarmed, the National Authority of Medicines and Health Products ...
The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...
This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on ...
The MRHA, which overseas the safety of medicines, vaccines and healthcare devices, was accused of not acting fast enough when ...
Amgen's dividend profile shines, but growth slows. See why AMGN stock faces regulatory risks and offers limited incentives ...
Zacks.com on MSN21h
Reasons to Hold West Pharmaceutical Stock in Your Portfolio NowWest Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and ...
We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...
Investors seeking a steadily growing passive income stream want to turn their heads toward the healthcare sector. Unlike with ...
The uptick in Glenmark Pharmaceuticals share price came after the company announced the launch of Phytonadione Injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback